Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred Buxton

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Arrhythmia & Electrophysiology Review|May 17, 2017
"What Would He Do Next?"Alfred Buxton
Medicine and Health, Rhode Island|June 1, 2004
Acute management of atrial fibrillationAlfred Buxton
Biometrics|July 20, 2013
Treatment benefit and treatment harm rate to characterize heterogeneity in treatment effectChangyu Shen, Jaesik Jeong, Xiaochun Li, et al.
Journal of Cardiovascular Electrophysiology|January 30, 2007
Coronary sinus and fossa ovalis ablation: effect on interatrial conduction and atrial fibrillationPeter Ott, Malcolm M Kirk, Charles Koo, et al.
Chest|June 19, 2007
The impact of cardiac resynchronization therapy on obstructive sleep apnea in heart failure patients: a pilot studyMichael L Stanchina, Kristin Ellison, Atul Malhotra, et al.
Annals of Epidemiology|December 24, 2013
Height and risk of sudden cardiac death: the Atherosclerosis Risk in Communities and Cardiovascular Health studiesMichael A Rosenberg, Faye L Lopez, Petra Bůžková, et al.
JAMA|July 5, 2018
Association of the US Department of Justice Investigation of Implantable Cardioverter-Defibrillators and Devices Not Meeting the Medicare National Coverage Determination, 2007-2015Nihar R Desai, Paul M Bourdillon, Craig S Parzynski, et al.
Circulation. Cardiovascular Quality and Outcomes|February 12, 2015
Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trialsPaul L Hess, Sana M Al-Khatib, Joo Y Han, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Arrhythmia & Electrophysiology Review|May 17, 2017
"What Would He Do Next?"Alfred Buxton
Medicine and Health, Rhode Island|June 1, 2004
Acute management of atrial fibrillationAlfred Buxton
Biometrics|July 20, 2013
Treatment benefit and treatment harm rate to characterize heterogeneity in treatment effectChangyu Shen, Jaesik Jeong, Xiaochun Li, et al.
Journal of Cardiovascular Electrophysiology|January 30, 2007
Coronary sinus and fossa ovalis ablation: effect on interatrial conduction and atrial fibrillationPeter Ott, Malcolm M Kirk, Charles Koo, et al.
Chest|June 19, 2007
The impact of cardiac resynchronization therapy on obstructive sleep apnea in heart failure patients: a pilot studyMichael L Stanchina, Kristin Ellison, Atul Malhotra, et al.
Annals of Epidemiology|December 24, 2013
Height and risk of sudden cardiac death: the Atherosclerosis Risk in Communities and Cardiovascular Health studiesMichael A Rosenberg, Faye L Lopez, Petra Bůžková, et al.
JAMA|July 5, 2018
Association of the US Department of Justice Investigation of Implantable Cardioverter-Defibrillators and Devices Not Meeting the Medicare National Coverage Determination, 2007-2015Nihar R Desai, Paul M Bourdillon, Craig S Parzynski, et al.
Circulation. Cardiovascular Quality and Outcomes|February 12, 2015
Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trialsPaul L Hess, Sana M Al-Khatib, Joo Y Han, et al.
Pageof 1